Skip to the main content
The Crier

Framework Agreement for the supply of pralidoxime chloride injection

Your saved contracts

What the buyer wrote

Framework Agreement has been established for the supply of pralidoxime chloride for injection, to place call-offorders as and when required during the life of the Framework Agreement. The duration of the Framework Agreement is 2 years with an option to extend for up to an additional 2 years.

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

Baxter Healthcare Ltdends (31 Mar 2022)

Details

What the buyer calls it
Framework Agreement for the supply of pralidoxime chloride injection
How they are buying
Advertised, shortlist firstSuppliers applied to be considered, and the buyer picked who went on to bid.
Type
goods
Work starts
31 Mar 2020
Work ends
31 Mar 2022

Who the buyer named

Donna Reynolds was the named contact on this notice.

donna.reynolds@dh.gsi.gov.uk